Table 1.
Baseline demographics and clinical characteristics of the enrolled patients (n = 30).
| Demographic Characteristics (n = 30) | |||
|---|---|---|---|
| Age | 30.82 ± 6.87 | ||
| Sexual activity | 26 (86.67%) | ||
| Smoking | 14 (46.67%) | ||
| Body mass index (kg/m2) | 22.94 ± 3.28 | ||
| <18.5 | 3 (10%) | ||
| 18.5–24.9 | 17 (56.67%) | ||
| 25–29.9 | 10 (33.34%) | ||
| ≥30 | 0 (0%) | ||
| Contraceptive use | 10 (33.34%) | ||
| Oral | 5 (16.67%) | ||
| Barrier | 4 (13.34%) | ||
| Others | 1 (3.34%) | ||
| Clinical Characteristics (n = 30) | |||
| Vulvovaginal signs and symptoms | Leucorrhoea | 30 (100%) | |
| Burning | 29 (96.67%) | ||
| Itching | 30 (100%) | ||
| Vulvo-vaginal erythema/edema | 30 (100%) | ||
| Subjective vulvar discomfort | 30 (100%) | ||
| Amsel Criteria | Homogenous vaginal discharge | 25 (83.33%) | |
| Clue cell presence | 22 (73.33%) | ||
| Positive amine test | 17 (56.67%) | ||
| Vaginal pH > 4.5 | 17 (56.67%) | ||
| Nugent score | 0–3 | 0 (0%) | |
| 4–6 | 0 (0%) | ||
| 7–10 | 30 (100%) | ||
| Lactobacillary grade | I | 0 (0%) | |
| II | 6 (20%) | ||
| III | 24 (80%) | ||